Chemistry of pyridoxine in drug design


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

Pyridoxine and its derivatives, pyridoxamine and pyridoxal, are the three main forms of vitamin B6, which play exceptionally important biological roles in living organisms. The active endogenous metabolites of these molecules, pyridoxal phosphate and pyridoxamine phosphate, are the most important coenzymes involved in a wide range of biochemical reactions necessary for cell activity, due to which pyridoxine and its derivatives are regarded as biologically privileged molecules. Taking into account also the wide possibilities for chemical modification of the pyridoxine structure, it is only natural for medicinal chemists to explore them in the design of novel drugs. This review summarizes the data on the main pharmacologically significant pyridoxine derivatives (including pyridoxamine and pyridoxal derivatives) reported in modern scientifi c and patent sources. Methods for their synthesis, key pharmacological properties, and medicinal chemistry concepts underlying the design of the developing physiologically active compounds are presented. The promising directions for future development of chemistry of physiologically active pyridoxine derivatives are also discussed.

Sobre autores

Y. Shtyrlin

Scientific and Educational Center of Pharmaceutics, Kazan (Volga Region) Federal University

Autor responsável pela correspondência
Email: yurii.shtyrlin@gmail.com
Rússia, 18 ul. Kremlevskaya, Kazan, 420008

A. Petukhov

Scientific and Educational Center of Pharmaceutics, Kazan (Volga Region) Federal University

Email: yurii.shtyrlin@gmail.com
Rússia, 18 ul. Kremlevskaya, Kazan, 420008

A. Strelnik

Scientific and Educational Center of Pharmaceutics, Kazan (Volga Region) Federal University

Email: yurii.shtyrlin@gmail.com
Rússia, 18 ul. Kremlevskaya, Kazan, 420008

N. Shtyrlin

Scientific and Educational Center of Pharmaceutics, Kazan (Volga Region) Federal University

Email: yurii.shtyrlin@gmail.com
Rússia, 18 ul. Kremlevskaya, Kazan, 420008

A. Iksanova

Scientific and Educational Center of Pharmaceutics, Kazan (Volga Region) Federal University

Email: yurii.shtyrlin@gmail.com
Rússia, 18 ul. Kremlevskaya, Kazan, 420008

M. Pugachev

Scientific and Educational Center of Pharmaceutics, Kazan (Volga Region) Federal University

Email: yurii.shtyrlin@gmail.com
Rússia, 18 ul. Kremlevskaya, Kazan, 420008

R. Pavelyev

Scientific and Educational Center of Pharmaceutics, Kazan (Volga Region) Federal University

Email: yurii.shtyrlin@gmail.com
Rússia, 18 ul. Kremlevskaya, Kazan, 420008

M. Dzyurkevich

Scientific and Educational Center of Pharmaceutics, Kazan (Volga Region) Federal University

Email: yurii.shtyrlin@gmail.com
Rússia, 18 ul. Kremlevskaya, Kazan, 420008

M. Garipov

Scientific and Educational Center of Pharmaceutics, Kazan (Volga Region) Federal University

Email: yurii.shtyrlin@gmail.com
Rússia, 18 ul. Kremlevskaya, Kazan, 420008

K. Balakin

Scientific and Educational Center of Pharmaceutics, Kazan (Volga Region) Federal University

Email: yurii.shtyrlin@gmail.com
Rússia, 18 ul. Kremlevskaya, Kazan, 420008


Declaração de direitos autorais © Springer Science+Business Media, LLC, part of Springer Nature, 2019

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies